{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T09:12:37Z","timestamp":1788426757207,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,9,3]],"date-time":"2027-09-03T00:00:00Z","timestamp":1819929600000},"content-version":"am","delay-in-days":337,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"NIH NCI","doi-asserted-by":"publisher","award":["P30CA008748"],"award-info":[{"award-number":["P30CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ijrobp.2026.03.032","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:59:02Z","timestamp":1774486742000},"page":"379-387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular Risk Stratification for Decision-Making Among Patients With Breast Cancer Eligible to Omit Radiation Therapy"],"prefix":"10.1016","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7962-4403","authenticated-orcid":false,"given":"Shoshana J.","family":"Rosenzweig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian A.","family":"Boe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah Y.","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Roth O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George E.","family":"Naoum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab","family":"Abou Yehia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Isabelle","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Hahesy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"El-Tamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon N.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atif J.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lior Z.","family":"Braunstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2026.03.032_bib0001","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1200\/JCO.2012.45.2615","article-title":"Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: Long-term follow-up of CALGB 9343","volume":"31","author":"Hughes","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.032_bib0002","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1470-2045(14)71221-5","article-title":"Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): A randomised controlled trial","volume":"16","author":"Kunkler","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.032_bib0003","unstructured":"\u00a9 National Comprehensive Cancer Network I. NCCN clinical practice guidelines in oncology (NCCN guidelines\u00ae) for breast cancer 5. 2025. Accessed October 22, 2025. https:\/\/www.nccn.org"},{"key":"10.1016\/j.ijrobp.2026.03.032_bib0004","unstructured":"PDQ\u00ae Adult Treatment Editorial Board. PDQ breast cancer treatment. Bethesda MNCI. Updated 04\/25\/2025. Accessed October 22, 2025. https:\/\/www.cancer.gov\/types\/breast\/hp\/breast-treatment-pdq"},{"key":"10.1016\/j.ijrobp.2026.03.032_bib0005","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1056\/NEJMoa2302344","article-title":"Omitting radiotherapy after breast-conserving surgery in luminal a breast cancer","volume":"389","author":"Whelan","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2026.03.032_bib0006","doi-asserted-by":"crossref","first-page":"TPS623","DOI":"10.1200\/JCO.2023.41.16_suppl.TPS623","article-title":"NRG-BR007: A phase III trial evaluating de-escalation of breast radiation (DEBRA) following breast-conserving surgery (BCS) of stage 1, hormone receptor+, HER2-, RS \u226418 breast cancer","volume":"41","author":"White","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.032_bib0007","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1245\/s10434-021-09903-1","article-title":"The clinical utility of DCISionRT(\u00ae) on radiation therapy decision making in patients with ductal carcinoma in situ following breast-conserving surgery","volume":"28","author":"Shah","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.032_bib0008","unstructured":"NLoM (US). EXamining PErsonalised radiation therapy for low-risk early breast cancer (EXPERT). ClinicalTrials.gov. Identifier NCT02889874. Updated September 18, 2025. Accessed October 22, 2025. https:\/\/clinicaltrials.gov\/study\/NCT02889874"},{"issue":"5_Supplement","key":"10.1016\/j.ijrobp.2026.03.032_bib0009","doi-asserted-by":"crossref","first-page":"OT1-12-02","DOI":"10.1158\/1538-7445.SABCS22-OT1-12-02","article-title":"Abstract OT1-12-02: Preliminary report of the PRECISION Trial (profiling early breast cancer for radiotherapy omission): A phase II study of breast-conserving surgery without adjuvant radiotherapy for favorable-risk breast cancer","volume":"83","author":"Braunstein","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2026.03.032_bib0010","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1200\/JCO.23.02270","article-title":"Omission of radiotherapy after breast-conserving surgery for women with breast cancer with low clinical and genomic risk: 5-year outcomes of IDEA","volume":"42","author":"Jagsi","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.032_bib0011","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1200\/JCO.2007.15.1068","article-title":"Development of the 21-gene assay and its application in clinical practice and clinical trials","volume":"26","author":"Sparano","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.032_bib0012","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1804710","article-title":"Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer","volume":"379","author":"Sparano","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2026.03.032_bib0013","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1056\/NEJMoa040587","article-title":"Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer","volume":"351","author":"Hughes","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2026.03.032_bib0014","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/jnci\/djy128","article-title":"Effects of radiotherapy in early-stage, low-recurrence risk, hormone-sensitive breast cancer","volume":"110","author":"Jayasekera","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2026.03.032_bib0015","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/jnci\/93.9.684","article-title":"Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial","volume":"93","author":"Fisher","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2026.03.032_bib0016","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/jnci\/89.22.1673","article-title":"Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer","volume":"89","author":"Fisher","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2026.03.032_bib0017","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1200\/JCO.2009.23.7610","article-title":"Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: Results from NSABP B-14 and NSABP B-20","volume":"28","author":"Mamounas","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.032_bib0018","doi-asserted-by":"crossref","first-page":"314","DOI":"10.4048\/jbc.2020.23.e36","article-title":"Impact of oncotype DX recurrence score on the patterns of locoregional recurrence in breast cancer (Korean Radiation Oncology Group 19-06)","volume":"23","author":"Kim","year":"2020","journal-title":"J Breast Cancer"},{"key":"10.1016\/j.ijrobp.2026.03.032_bib0019","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.2217\/fon-2018-0967","article-title":"The 21-gene recurrence score and effects of adjuvant radiotherapy after breast conserving surgery in early-stage breast cancer","volume":"15","author":"Dong","year":"2019","journal-title":"Future Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.032_bib0020","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.ijrobp.2025.04.044","article-title":"Partial breast irradiation for high molecular risk early-stage breast cancer","volume":"123","author":"Terry","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.03.032_bib0021","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10549-017-4381-7","article-title":"21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer","volume":"166","author":"Turashvili","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2026.03.032_bib0022","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s10549-012-2072-y","article-title":"Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 study","volume":"134","author":"Solin","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2026.03.032_bib0023","doi-asserted-by":"crossref","first-page":"djw259","DOI":"10.1093\/jnci\/djw259","article-title":"21-Gene recurrence score and locoregional recurrence in node-positive\/ER-positive breast cancer treated with chemo-endocrine therapy","volume":"109","author":"Mamounas","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2026.03.032_bib0024","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s10549-022-06580-w","article-title":"Value of the 21-gene expression assay in predicting locoregional recurrence rates in estrogen receptor-positive breast cancer: A systematic review and network meta-analysis","volume":"193","author":"Davey","year":"2022","journal-title":"Breast Cancer Res Treat"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626005171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626005171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T08:16:38Z","timestamp":1788423398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301626005171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0360301626005171"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.03.032","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Risk Stratification for Decision-Making Among Patients With Breast Cancer Eligible to Omit Radiation Therapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.03.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}